FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097920708> ?p ?o ?g. }

• W2097920708 endingPage "811" @default.
• W2097920708 startingPage "805" @default.
• W2097920708 abstract "Background Acute exacerbations of COPD reflect in part an inappropriate host response to abnormal bacterial colonization. Orally administered inactivated nontypeable Haemophilus influenzae (NTHi) can drive a specific T-cell response that by promoting intrabronchial phagocytosis down-regulates bronchus inflammation. Methods Subjects with recurrent exacerbations of COPD were studied in a randomized, multicenter, double-blind, placebo-controlled trial, to test efficacy of an NTHi oral immunotherapeutic (HI-164OV). This report describes the outcome in 38 subjects with severe COPD defined as having an FEV1 ≤ 50% of predicted normal. Results Exacerbations defined as an increase in volume and purulence of sputum were reduced by 16% (not significant) in the active group. However, moderate-to-severe exacerbations (defined as requiring corticosteroid therapy) were reduced by 63% (P = .05). The proportion with any acute exacerbation was little changed with treatment, but the proportion with episodes requiring corticosteroid therapy was reduced by 56% (P = .07). The mean duration of episodes was reduced by 37% (P = .01) and prescribed courses of antibiotics were reduced by 56% (P = .03) following therapy. Exacerbations requiring admission into hospital were reduced by 90% (P = .04) in the active group. No specific adverse effect was detected. Conclusions Treatment of severe COPD with frequent exacerbations with HI-164OV was safe and effective, especially with respect to reduction in parameters of severity. Trial registration Australian New Zealand Clinical Trials Registry, www.anzctr.org.au; identifier: ACTRN012606000074594. Acute exacerbations of COPD reflect in part an inappropriate host response to abnormal bacterial colonization. Orally administered inactivated nontypeable Haemophilus influenzae (NTHi) can drive a specific T-cell response that by promoting intrabronchial phagocytosis down-regulates bronchus inflammation. Subjects with recurrent exacerbations of COPD were studied in a randomized, multicenter, double-blind, placebo-controlled trial, to test efficacy of an NTHi oral immunotherapeutic (HI-164OV). This report describes the outcome in 38 subjects with severe COPD defined as having an FEV1 ≤ 50% of predicted normal. Exacerbations defined as an increase in volume and purulence of sputum were reduced by 16% (not significant) in the active group. However, moderate-to-severe exacerbations (defined as requiring corticosteroid therapy) were reduced by 63% (P = .05). The proportion with any acute exacerbation was little changed with treatment, but the proportion with episodes requiring corticosteroid therapy was reduced by 56% (P = .07). The mean duration of episodes was reduced by 37% (P = .01) and prescribed courses of antibiotics were reduced by 56% (P = .03) following therapy. Exacerbations requiring admission into hospital were reduced by 90% (P = .04) in the active group. No specific adverse effect was detected. Treatment of severe COPD with frequent exacerbations with HI-164OV was safe and effective, especially with respect to reduction in parameters of severity." @default.
• W2097920708 created "2016-06-24" @default.
• W2097920708 creator A5027241938 @default.
• W2097920708 creator A5037430904 @default.
• W2097920708 creator A5046341745 @default.
• W2097920708 creator A5054188186 @default.
• W2097920708 creator A5055883719 @default.
• W2097920708 creator A5070726309 @default.
• W2097920708 date "2010-04-01" @default.
• W2097920708 modified "2023-10-16" @default.
• W2097920708 title "Oral Immunotherapy With Inactivated Nontypeable Haemophilus influenzae Reduces Severity of Acute Exacerbations in Severe COPD" @default.
• W2097920708 cites W1969704556 @default.
• W2097920708 cites W1999939412 @default.
• W2097920708 cites W2010967671 @default.
• W2097920708 cites W2045558608 @default.
• W2097920708 cites W2056059631 @default.
• W2097920708 cites W2061092450 @default.
• W2097920708 cites W2077672954 @default.
• W2097920708 cites W2090110893 @default.
• W2097920708 cites W2106425603 @default.
• W2097920708 cites W2117837864 @default.
• W2097920708 cites W2118704923 @default.
• W2097920708 cites W2120629366 @default.
• W2097920708 cites W2138825039 @default.
• W2097920708 cites W2142724633 @default.
• W2097920708 cites W2149849734 @default.
• W2097920708 cites W2164800159 @default.
• W2097920708 cites W2316564871 @default.
• W2097920708 cites W4211263216 @default.
• W2097920708 doi "https://doi.org/10.1378/chest.09-1382" @default.
• W2097920708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19952063" @default.
• W2097920708 hasPublicationYear "2010" @default.
• W2097920708 type Work @default.
• W2097920708 sameAs 2097920708 @default.
• W2097920708 citedByCount "43" @default.
• W2097920708 countsByYear W20979207082012 @default.
• W2097920708 countsByYear W20979207082013 @default.
• W2097920708 countsByYear W20979207082014 @default.
• W2097920708 countsByYear W20979207082015 @default.
• W2097920708 countsByYear W20979207082016 @default.
• W2097920708 countsByYear W20979207082017 @default.
• W2097920708 countsByYear W20979207082019 @default.
• W2097920708 countsByYear W20979207082020 @default.
• W2097920708 countsByYear W20979207082021 @default.
• W2097920708 countsByYear W20979207082022 @default.
• W2097920708 countsByYear W20979207082023 @default.
• W2097920708 crossrefType "journal-article" @default.
• W2097920708 hasAuthorship W2097920708A5027241938 @default.
• W2097920708 hasAuthorship W2097920708A5037430904 @default.
• W2097920708 hasAuthorship W2097920708A5046341745 @default.
• W2097920708 hasAuthorship W2097920708A5054188186 @default.
• W2097920708 hasAuthorship W2097920708A5055883719 @default.
• W2097920708 hasAuthorship W2097920708A5070726309 @default.
• W2097920708 hasConcept C126322002 @default.
• W2097920708 hasConcept C142724271 @default.
• W2097920708 hasConcept C168563851 @default.
• W2097920708 hasConcept C197934379 @default.
• W2097920708 hasConcept C204787440 @default.
• W2097920708 hasConcept C27081682 @default.
• W2097920708 hasConcept C2776301714 @default.
• W2097920708 hasConcept C2776780178 @default.
• W2097920708 hasConcept C2776804153 @default.
• W2097920708 hasConcept C2776925733 @default.
• W2097920708 hasConcept C2777014857 @default.
• W2097920708 hasConcept C2781069245 @default.
• W2097920708 hasConcept C501593827 @default.
• W2097920708 hasConcept C71924100 @default.
• W2097920708 hasConcept C86803240 @default.
• W2097920708 hasConcept C89423630 @default.
• W2097920708 hasConceptScore W2097920708C126322002 @default.
• W2097920708 hasConceptScore W2097920708C142724271 @default.
• W2097920708 hasConceptScore W2097920708C168563851 @default.
• W2097920708 hasConceptScore W2097920708C197934379 @default.
• W2097920708 hasConceptScore W2097920708C204787440 @default.
• W2097920708 hasConceptScore W2097920708C27081682 @default.
• W2097920708 hasConceptScore W2097920708C2776301714 @default.
• W2097920708 hasConceptScore W2097920708C2776780178 @default.
• W2097920708 hasConceptScore W2097920708C2776804153 @default.
• W2097920708 hasConceptScore W2097920708C2776925733 @default.
• W2097920708 hasConceptScore W2097920708C2777014857 @default.
• W2097920708 hasConceptScore W2097920708C2781069245 @default.
• W2097920708 hasConceptScore W2097920708C501593827 @default.
• W2097920708 hasConceptScore W2097920708C71924100 @default.
• W2097920708 hasConceptScore W2097920708C86803240 @default.
• W2097920708 hasConceptScore W2097920708C89423630 @default.
• W2097920708 hasIssue "4" @default.
• W2097920708 hasLocation W20979207081 @default.
• W2097920708 hasLocation W20979207082 @default.
• W2097920708 hasOpenAccess W2097920708 @default.
• W2097920708 hasPrimaryLocation W20979207081 @default.
• W2097920708 hasRelatedWork W2043069487 @default.
• W2097920708 hasRelatedWork W2154513067 @default.
• W2097920708 hasRelatedWork W2252383104 @default.
• W2097920708 hasRelatedWork W2360743014 @default.
• W2097920708 hasRelatedWork W2398856609 @default.
• W2097920708 hasRelatedWork W2951336120 @default.
• W2097920708 hasRelatedWork W3047874532 @default.
• W2097920708 hasRelatedWork W3142286882 @default.

• next